Global GI Stool Testing Market Trends and Growth Analysis 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The GI Stool Testing Market Expected To Expand Between 2025 And 2029?

The gi stool testing market has experienced robust expansion in recent years. Its size is projected to increase from $1.32 billion in 2024 to $1.41 billion by 2025, driven by a compound annual growth rate (CAGR) of 6.5%. The growth observed historically can be attributed to the rising prevalence of gastrointestinal diseases, increased awareness of gut health, the growing adoption of automated systems, increasing disposable income, and an expanding geriatric population.

The gi stool testing market is anticipated to experience robust expansion over the next few years, projected to reach $1.86 billion in 2029, with a compound annual growth rate (CAGR) of 7.3%. This growth during the forecast period is primarily fueled by an escalating demand for efficient diagnostic instruments, the increasing occurrence of colorectal cancer, a rise in healthcare expenditure, growing consumption of fast food, and an intensified focus on personalized medicine. Prominent trends identified for this period include groundbreaking diagnostic technologies, the integration of molecular diagnostics, advancements in biologics, the evolution of personalized medicine, and strategic collaboration initiatives.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23410&type=smp

Which Factors And Drivers Are Influencing The GI Stool Testing Market In 2025?

A growing incidence of gastrointestinal disorders is anticipated to fuel the expansion of the GI stool testing market in the future. These disorders encompass ailments impacting the digestive system, such as the stomach, intestines, and associated organs, leading to symptoms like nausea, diarrhea, constipation, and abdominal pain. The surge in gastrointestinal issues primarily stems from unhealthy eating patterns, where higher intake of processed items, elevated sugar consumption, and diets lacking fiber disturb gut flora, diminish digestive well-being, and foster conditions like acid reflux, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). GI stool testing becomes essential for gastrointestinal disorders to identify infections, inflammation, or digestive imbalances, offering assistance in pinpointing pathogens (bacteria, viruses, parasites), indicators of gut inflammation, and shortages of digestive enzymes, thereby facilitating precise diagnosis and focused therapy. As an illustration, in September 2024, the Centers for Disease Control and Prevention, a US-based government agency, indicated that from 2024 to 2025, states participating in NoroSTAT documented 1,676 norovirus outbreaks, representing a notable increase compared to the 729 outbreaks reported during the corresponding period in the prior season. Consequently, the growing occurrence of gastrointestinal disorders fuels the expansion of the GI stool testing market.

What Are The Leading Segments Analyzed In The GI Stool Testing Market?

The gi stool testingmarket covered in this report is segmented –

1) By Type: Immunoassay Test; Molecular Diagnostic Test; Chromatography-Based Test; Microbiological Culture Test; Enzyme-Linked Immunosorbent Assay (ELISA)

2) By Sample Type: Fecal Samples; Serum Samples

3) By Equipment: Automated Analyzers; Benchtop Instruments; Portable Devices

4) By Application: Diagnosis Of Gastrointestinal Disorders; Screening For Colorectal Cancer; Monitoring Of Inflammatory Bowel Disease (IBD); Detection Of Gastrointestinal Infections; Evaluation Of Digestive Health

5) By End User: Hospital; Diagnostic Centre And Laboratory; Academic Institution; Research Centre Organization; Homecare; Other End Users

Subsegments:

1) By Immunoassay Test: Rapid Immunoassay; Lateral Flow Assay; Fluorescent Immunoassay

2) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR); Nucleic Acid Amplification Test (NAAT); Next-Generation Sequencing (NGS)

3) By Chromatography-Based Test: Gas Chromatography (GC); Liquid Chromatography (LC); Thin-Layer Chromatography (TLC)

4) By Microbiological Culture Test: Aerobic Culture; Anaerobic Culture; Selective Media Culture

5) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA; Indirect ELISA; Sandwich ELISA; Competitive ELISA

How Are Trends Influencing The GI Stool Testing Market?

Leading firms within the GI stool testing market are prioritizing sophisticated testing methods, particularly comprehensive diagnostic tests, to enhance precision, efficiency, and prompt identification of diseases. A comprehensive diagnostic test represents an advanced medical instrument designed to concurrently assess numerous health indicators, providing an exhaustive evaluation of a particular ailment. An example of this is the launch of GI Detect in November 2024 by EmeritusDX, a US-based diagnostics company, which is a comprehensive diagnostic test engineered to assist healthcare professionals in diagnosing gastrointestinal conditions. This innovative test employs a single stool swab to identify 26 different bacteria, viruses, and parasites linked to disturbances in the digestive system. Boasting a 24-hour turnaround time, GI Detect facilitates rapid and well-informed clinical decisions. Beyond its extensive pathogen detection capabilities, the test also screens for Helicobacter pylori along with its virulence factors—VacA, cagA, and babA—and common gastrointestinal parasites including Cryptosporidium, Entamoeba histolytica, and Giardia lamblia. This all-encompassing strategy guarantees precise and prompt diagnosis of gastrointestinal infections.

Who Are The Key Multinational Companies Dominating The GI Stool Testing Market?

Major companies operating in the gi stool testing market are Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Hologic Inc., Biomerieux SA, Bio-Rad Laboratories Inc., Meridian BioScience Inc., Diasorin SPA, Helena Laboratories Corporation, ELITechGroup, Genova Diagnostics Inc., Genesis Laboratory Management LLC, US BioTek Laboratories LLC, Doctor’s Data Inc., Diagnostic Solutions Laboratory LLC, Serosep Ltd., Atlas Laboratories Ltd., VDI Laboratory LLC, Functional Medical Institute Pvt. Ltd., Walk-In Lab LLC, ScheBo Biotech AG.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/gi-stool-testing-global-market-report

Which Geographies Are Emerging As Strong Markets For The GI Stool Testing Industry?

North America was the largest region in the GI stool testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gi stool testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The GI Stool Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=23410&type=smp

Browse Through More Reports Similar to the Global GI Stool Testing Market 2025, By The Business Research Company

Application Testing Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/application-testing-services-global-market-report

Automation Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/automation-testing-global-market-report

Bioanalytical Testing Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bioanalytical-testing-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795